Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Pembrolizumab combined with Chemotherapy
DRUG
2 trials
Sponsors
Xiaorong Dong
, Yuankai Shi
Conditions
Chemotherapy
Gut Microbiota
Head and Neck Squamous Cell Carcinoma
NSCLC
Pembrolizumab
Phase 1
Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy
NCT04333004
Xiaorong Dong
Chemotherapy, Gut Microbiota, NSCLC +1
Start: 2020-04-30
End: 2022-04-30
Target: 40
Updated: 2020-04-03
Phase 2
Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China
Recruiting
NCT04857164
Yuankai Shi
Head and Neck Squamous Cell Carcinoma
Start: 2021-04-30
End: 2026-01-01
Target: 150
Updated: 2025-01-28
Related Papers
Pembrolizumab combined with nab-paclitaxel and platinum in recurrent/metastatic HNSCC: efficacy, safety, and survival predictive model.
2026-05-19
Pembrolizumab plus nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): A prospective, single-arm, open-label, phase 2 study.
Journal of Clinical Oncology
2024-06-01
2 citations